首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >A COST EFFECTIVENESS ANALYSIS OF ROSUVASTATIN AGAINST ATORVASTATIN IN CARDIOVASCULAR DISEASES AND STROKE: AN AMBISPECTIVE STUDY

【24h】

A COST EFFECTIVENESS ANALYSIS OF ROSUVASTATIN AGAINST ATORVASTATIN IN CARDIOVASCULAR DISEASES AND STROKE: AN AMBISPECTIVE STUDY

机译：罗伐他汀抗阿托伐他汀在心血管疾病和卒中中的成本效果分析：一项敏锐的研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2016年第7期|共1页
作者
Deepthy B.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. A COST EFFECTIVENESS ANALYSIS OF ROSUVASTATIN AGAINST ATORVASTATIN IN CARDIOVASCULAR DISEASES AND STROKE: AN AMBISPECTIVE STUDY [J] . Deepthy B. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：罗伐他汀抗阿托伐他汀在心血管疾病和卒中中的成本效果分析：一项敏锐的研究
2. Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model Analysis [J] . Han Yang, Nan Li, Youlian Zhou, Drug Design, Development and Therapy . 2020,第1期

机译：Ezetimibe作为中等剂量罗萨伐他汀与高剂量罗萨伐他汀在中国心血管疾病二次预防中的高剂量rosuvastatin的成本效果分析：Markov模型分析
3. Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS) [J] . M. Raikou, A. McGuire, H. M. Colhoun, Diabetologia . 2007,第4期

机译：阿托伐他汀在2型糖尿病中一级预防心血管疾病的成本效益：阿托伐他汀糖尿病合作研究（CARDS）的结果
4. Novel approaches for medication compliance and effectiveness analysis and support in cardiovascular disease patients [C] . Chouvarda Ioanna, Gkontra Polyxeni, Kokonozi Athina, 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2011

机译：用于心血管疾病患者的药物依从性和有效性分析与支持的新方法
5. Application of WHO-CHOICE for cost-effectiveness analysis of interventions to prevent cardiovascular disease in Vietnam. [D] . Ha, Duc Anh. 2010

机译：WHO-CHOICE在越南预防心血管疾病的干预措施的成本效益分析中的应用。
6. Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model Analysis [O] . Han Yang, Nan Li, Youlian Zhou, 2020

机译：依泽替米贝作为中剂量瑞舒伐他汀与高剂量瑞舒伐他汀在中国心血管疾病的二级预防中的附加治疗的成本-效果分析：马尔可夫模型分析
7. A Cost Effectiveness Analysis of Rosuvastatin Against Atorvastatin in Cardiovascular Diseases and Stroke: An Ambispective Study [O] . B Deepthy 2016

机译：罗苏伐他汀在心血管疾病和中风患者中的成本效果分析：中脑卒中中的血管脱落
8. The Implications of Cost-Effectiveness Analysis of Medical Technology. Background Paper No. 2: Case Studies of Medical Technologies. Case Study No. 5: Periodontal Disease. Assessing the Effectiveness and Costs of the Keyes Technique [R] . Scheffler, R. M. , Rovin, S. 1981

机译：医疗技术成本效益分析的启示。背景文件第2号：医疗技术案例研究。案例研究第5号：牙周病。评估Keyes技术的有效性和成本

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号